Your browser doesn't support javascript.
loading
Update on the Use of Botulinum Toxin Therapy for Focal and Task-Specific Dystonias.
Lungu, Codrin; Ahmad, Omar F.
Afiliação
  • Lungu C; Office of the Clinical Director, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland.
  • Ahmad OF; Office of the Clinical Director, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland.
Semin Neurol ; 36(1): 41-6, 2016 Feb.
Article em En | MEDLINE | ID: mdl-26866495
ABSTRACT
Focal dystonia is defined by anatomical distribution and represents a distinct entity from generalized dystonia. Task-specific dystonia occurs in the context of specific patterns of movement. Botulinum neurotoxin (BoNT) injections are the treatment of choice in most cases. Several formulations are available; the approved indications, dosing, and some administration details, differ between them. The major forms of focal and task-specific dystonia are reviewed, along with the evidence for BoNT therapy, the expected benefit and side effects, and practical points guiding the injections.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Toxinas Botulínicas / Distúrbios Distônicos Tipo de estudo: Diagnostic_studies Limite: Animals / Humans Idioma: En Revista: Semin Neurol Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Toxinas Botulínicas / Distúrbios Distônicos Tipo de estudo: Diagnostic_studies Limite: Animals / Humans Idioma: En Revista: Semin Neurol Ano de publicação: 2016 Tipo de documento: Article